[News Brief] Nuance Pharma Secures IND Approval for Actair® Trial
Nuance Pharma has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration to begin a Phase III…
Asia Pharmaceuticals & Supplements
[News Brief] HKSAR Government Promotes Health Innovation in Switzerland
The Secretary for Health of Hong Kong SAR, Professor Lo Chung-mau, met multinational pharmaceutical and healthcare companies in Zurich, Switzerland…
[News Brief] KM Biologics and Serum Institute of India Enters Vaccine Collaboration
KM Biologics, a group company of Meiji Seika Pharma, has entered into a technology collaboration with Serum Institute of India…
[News Brief] Formosa Pharmaceuticals and SERI Partner for Ophthalmic Research
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have announced a research collaboration to develop ophthalmic formulations for corneal…
[News Brief] Formosa Pharmaceuticals and Singapore Eye Research Institute Partner on Ophthalmic Formulations
Formosa Pharmaceuticals and the Singapore Eye Research Institute (SERI) have entered a research collaboration to develop ophthalmic formulations for corneal…
[News Brief] International Vaccine Institute and Hilleman Laboratories Form Vaccine Development Partnership
The International Vaccine Institute (IVI) and Hilleman Laboratories have entered a strategic partnership to collaborate on the development of vaccines…
[News Brief] Everest Medicines Signs Share Purchase Agreement with Hasten Biopharmaceuticals
Everest Medicines has entered a share purchase agreement to acquire Hasten Biopharmaceuticals (SG) Pte. Ltd., aiming to expand its commercial…
[News Brief] UBT251 Phase 2 Trial Shows HbA1c Reduction in Chinese Patients with Type 2 Diabetes
United Biotechnology and Novo Nordisk have reported topline results from a phase 2 trial of UBT251 in Chinese patients with…
[News Brief] Next Generation Sequencing Gains Traction in APAC Biologics
PathoQuest highlighted the growing adoption of next generation sequencing (NGS) in Asia-Pacific biologics development, supporting viral safety, contamination detection, and…
[News Brief] Galderma Expands Restylane Portfolio with Two New Launches in Japan
Galderma has launched Restylane Defyne and Restylane Refyne, the first Optimal Balance Technology (OBT)–based hyaluronic acid injectables authorised in Japan.…